@misc{indiciae82dd31725379,
  title = {The clinical drug candidate ebselen attenuates inflammation and promotes microbiome recovery after antibiotic treatment for Clostridium difficile infection},
  author = {Garland, M. and Hryckowian, A. J. and Tholen, M. and Loscher, S. and Van Treuren, W. W. and Oresic Bender, K. and Sonnenburg, J. L. and Bogyo, M.},
  year = {2019},
  doi = {10.1101/827329},
  url = {https://www.biorxiv.org/content/10.1101/827329v1},
  note = {Source identifier: 10.1101/827329}
}